Refractory diabetic ketoacidosis secondary to sodium-glucose co-transporter 2 inhibitor use

被引:0
|
作者
Ravishankar, Nivedha [1 ]
Clayton, Samantha [1 ]
机构
[1] West Suffolk Hosp, Bury St Edmunds, Suffolk, England
关键词
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
016
引用
收藏
页码:14 / 14
页数:1
相关论文
共 50 条
  • [1] Severe euglycemic diabetic ketoacidosis secondary to sodium-glucose co-transporter 2 inhibitor: case report and literature review
    El Ess, Malak S.
    ElRishi, Mohamed A.
    ANNALS OF MEDICINE AND SURGERY, 2023, 85 (05): : 2097 - 2101
  • [2] Sodium-glucose co-transporter 2 inhibitors Think twice about diabetic ketoacidosis
    Markey, Annabel G.
    Scott, Taylor A.
    Killen, Judith C.
    Venter, Jan A.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2018, 47 (04) : 223 - 225
  • [3] Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors
    Isaacs, Michelle
    Tonks, Katherine T.
    Greenfield, Jerry R.
    INTERNAL MEDICINE JOURNAL, 2017, 47 (06) : 701 - 704
  • [4] Identifying features of sodium-glucose co-transporter 2 inhibitor (SGLT2i)-associated Diabetic Ketoacidosis (DKA)
    Stirling, A.
    Rollo, J.
    Kernohan, A.
    McGrane, D.
    DIABETOLOGIA, 2019, 62 : S362 - S362
  • [5] SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS AND THE POTENTIAL FOR DIABETIC KETOACIDOSIS
    Melnick, Stephen
    Basnet, Sijan
    Sharma, Priyadarshani
    Nazir, Salik
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S617 - S618
  • [6] Sodium-glucose Co-transporter 2 inhibitors and the risk of diabetic ketoacidosis: A multicenter international cohort study
    Douros, Antonios
    Lix, Lisa M.
    Fralick, Michael
    Dell'Aniello, Sophie
    Shah, Baiju R.
    Ronksley, Paul E.
    Tremblay, Eric
    Hu, Nianping
    Alessi-Severini, Silvia
    Fisher, Anat
    Bugden, Shawn C.
    Ernst, Pierre
    Filion, Kristian B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 589 - 590
  • [7] Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co-transporter 2 inhibitors
    Lakusic, Nenad
    Merkas, Ivana Sopek
    Sliskovic, Ana Marija
    Cerovec, Dora
    WORLD JOURNAL OF CARDIOLOGY, 2022, 14 (10): : 561 - 564
  • [8] A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care
    Taverner, Sofia
    Eng, Cindy
    Watson, Rebecca
    George, Siba
    Edwards, Amanda
    Williams, David M.
    Stephens, Jeffrey W.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (12)
  • [9] Possible risk factors for the development of sodium-glucose co-transporter 2 inhibitor-associated diabetic ketoacidosis in type 2 diabetes
    West, Kate
    Webb, Lucy-Anne
    Fenech, Matthew
    Dhatariya, Ketan
    BRITISH JOURNAL OF DIABETES, 2016, 16 (02): : 78 - 81
  • [10] Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use
    Melnick, Stephen
    Rajagopalan, Priya
    Lynn, Theresa
    Donato, Anthony
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2018, 8 (05): : 315 - 316